| Hepatoprotective role for ERMP1 in MASLD-driven hepatocarcinogenesis and β-catenin-mutated tumors | Cancer letters |  | | 2026 | 21 | 38 |
|
| MicroRNAs as Regulators of Hepatic Metabolism and Carcinogenesis | |  | | 2026 | 5 | 1 |
|
| Paracellular transport along the nephron in physiology and pathophysiology | Current opinion in nephrology and hypertension |  | | 2026 | 18 | 0 |
|
| The enigma of ENaC activation by proteolytic cleavage: a never ending quest ? | Pflügers Archiv |  | | 2025 | 51 | 0 |
|
| Comparative analysis of S100A10 and S100A11 in MASLD and hepatic cancer development revealed a tumor suppressive role for S100A10 | Cell death and disease |  | | 2025 | 52 | 22 |
|
| ERMP1 as a newly identified ER stress gatekeeper in chronic kidney disease | American journal of physiology. Renal physiology |  | | 2025 | 126 | 163 |
|
| Hepatic IR and IGF1R signaling govern distinct metabolic and carcinogenic processes upon PTEN deficiency in the liver | JHEP reports |  | | 2025 | 136 | 277 |
|
| Hepatic miR-149-5p upregulation fosters steatosis, inflammation and fibrosis development in mice and in human liver organoids | JHEP reports |  | | 2024 | 97 | 119 |
|
| Endoplasmic reticulum stress in renal cell carcinoma | International journal of molecular sciences |  | | 2023 | 170 | 312 |
|
| TIA1 loss exacerbates fatty liver disease but exerts a dual role in hepatocarcinogenesis | Cancers |  | | 2022 | 290 | 389 |
|
| S100 proteins in fatty liver disease and hepatocellular carcinoma | International journal of molecular sciences |  | | 2022 | 331 | 158 |
|
| MiR-22 deficiency fosters hepatocellular carcinoma development in fatty liver | Cells |  | | 2022 | 275 | 259 |
|
| Mir-21 Suppression Promotes Mouse Hepatocarcinogenesis | Cancers |  | | 2021 | 262 | 521 |
|
| Tristetraprolin promotes hepatic inflammation and tumor initiation but restrains cancer progression to malignancy | Cellular and Molecular Gastroenterology and Hepatology |  | | 2020 | 290 | 250 |
|
| Genetic ablation of MiR-22 fosters diet-induced obesity and NAFLD development | Journal of Personalized Medicine |  | | 2020 | 360 | 217 |
|
| mRNA post-transcriptional regulation by AU-rich element-binding proteins in liver inflammation and cancer | International Journal of Molecular Sciences |  | | 2020 | 366 | 106 |
|
| Deciphering miRNAs' action through miRNA editing | International Journal of Molecular Sciences |  | | 2019 | 243 | 258 |
|
| miRNAs and NAFLD: from pathophysiology to therapy | Gut |  | | 2019 | 439 | 2,596 |
|